PAVmed Reports Preliminary Third-Quarter 2026 Results and Medicare EsoGuard Coverage

PAVmed (PAVM) reported preliminary third-quarter 2026 revenue of $41,000 and a net loss of $13.0 million. Operating expenses were approximately $6.8 million for the quarter ended September 30, including $1.0 million of stock-based compensation expense.

The company said Lucid Diagnostics began receiving Medicare payments for EsoGuard in October, while Veris Health completed design freeze for its implantable physiological monitor and began a 90-day GLP animal study.

• Lucid performed 2,871 EsoGuard tests and recognized $1.2 million in third-quarter revenue.
• October EsoGuard test volume exceeded 1,800 tests, a record monthly level.
• PAVmed reported $8.9 million in cash and cash equivalents as of September 30, including $5.3 million of restricted cash.
• Veris expects an early 2027 FDA 510(k) submission for its implantable monitor.
• PAVmed held an initial FDA meeting on PortIO and expects an in-person pre-submission meeting in January 2027.

$PAVM Hedge Fund Activity

We have seen 10 institutional investors add shares of $PAVM stock to their portfolio, and 9 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• FIRST MANHATTAN CO. LLC. added 309,106 shares (+1298.5%) to their portfolio in Q2 2026, for an estimated $1,836,089
• BLACKROCK, INC. added 14,676 shares (+607.5%) to their portfolio in Q2 2026, for an estimated $87,175
• GEODE CAPITAL MANAGEMENT, LLC removed 7,212 shares (-19.7%) from their portfolio in Q3 2026, for an estimated $26,612
• GSA CAPITAL PARTNERS LLP removed 2,197 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $13,050
• TOWER RESEARCH CAPITAL LLC (TRC) removed 622 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $3,694
• PARKSIDE FINANCIAL BANK & TRUST added 246 shares (+inf%) to their portfolio in Q3 2026, for an estimated $907
• BARCLAYS PLC removed 75 shares (-100.0%) from their portfolio in Q3 2026, for an estimated $276

To track hedge funds' stock portfolios, check out Investivoq's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Investivoq API 13F endpoint.